Aquestive Therapeutics, Inc. is a biopharmaceutical company based in Warren, New Jersey, dedicated to developing innovative therapies that address significant unmet medical needs in neurology and orphan diseases. Leveraging its proprietary technologies, the company is advancing a diverse pipeline of product candidates aimed at enhancing patient outcomes and improving access to vital medications both domestically and internationally. With a focus on strategic collaborations and patient-centered solutions, Aquestive is well-positioned to drive meaningful advancements in the pharmaceutical sector and contribute to better healthcare outcomes.